The secretory phospholipase A₂ group IIA: a missing link between inflammation, activated renin-angiotensin system, and atherogenesis?

References

• AntonioVBrouilletAJanvierBTranscriptional regulation of the rat type IIA phospholipase A2 gene by cAMP and interleukin-1b in vascular smooth muscle cells: interplay of the CCAAT/enhancer binding protein (C/EBP), nuclear factor-kB and Ets transcription factorsBiochem J20023684152412188923
   PubMed Web of Science ®Google Scholar
• ArbibeLKoumanovKVialDGeneration of lyso-phospholipids from surfactant in acute lung injury is mediated by type-II phospholipase A2 and inhibited by a direct surfactant protein A-phospholipase A2 protein interactionJ Clin Invest19981021152609739049
   PubMed Web of Science ®Google Scholar
• AviramMMaorIPhospholipase A2-modified LDL is taken up at enhanced rate by macrophagesBiochim Biophys Res Commun199218546572
   PubMed Web of Science ®Google Scholar
• BalboaMABalsindeJWinsteadMVNovel group V phospholipase A2 involved in arachidonic acid mobilization in murine P388D1 macrophagesJ Biol Chem19962713238148943302
   PubMed Web of Science ®Google Scholar
• BalsindeJDennisEAInflammatory activation of arachidonic acid signaling in murine P388D1 macrophages via sphingomyelin synthesisJ Biol Chem19972722037379252342
   PubMed Web of Science ®Google Scholar
• BarbourSEDennisEAAntisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388Dresden cellsJ Biol Chem199326821875828408042
   PubMed Web of Science ®Google Scholar
• BezzineSKoduriRSValentinEExogenously added human group X secreted phospholipase A2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cellsJ Biol Chem2000275317910652303
   PubMed Web of Science ®Google Scholar
• BoekholdtSMKellerTTWarehamNJSerum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women The EPIC-Norfolk Prospective Population StudyArterioscler Thromb Vasc Biol2005258394615692105
   PubMed Web of Science ®Google Scholar
• BonventreJVThe 85-kD cytosolic phospholipase A2 knockout mouse: a new tool for physiology and cell biologyJ Am Soc Nephrol1999104041210215342
   PubMed Web of Science ®Google Scholar
• CassisLARateriDLLuHBone marrow transplantation reveals that recipient AT1a receptors are required to initiate Angiotensin II–induced atherosclerosis and aneurysmsArterioscler Thromb Vasc Biol200727380617158350
   PubMed Web of Science ®Google Scholar
• CrowlRMStollerTJConroyRRInduction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute-phase responseJ Biol Chem19912662647511846631
   PubMed Web of Science ®Google Scholar
• de BeerFCde BeerMCvan der WesthuyzenDRSecretory non-pancreatic phospholipase A2: influence on lipoprotein metabolismJ Lipid Res199738223299392421
   PubMed Web of Science ®Google Scholar
• de BeerFCConnellPMYuJHDL modification by secretory phospholipase A2 promotes scavenger receptor class B type I interaction and accelerates HDL catabolismJ Lipid Res20004118495711060355
   PubMed Web of Science ®Google Scholar
• DivchevDGrothusenChLuchtefeldMPersonal communication Impact of a combined treatment of angiotensin II type 1 receptor blockade and HMG-CoA-reductase inhibition on secretory phospholipase A2-type IIA and low density lipoprotein oxidation in patients with coronary artery diseaseEur Heart J Manuscript Number: EURHEARTJ-D-07-01269, under review
   Google Scholar
• EckeyRMenschikowskiMLattkePMinimal oxidation and storage of low density lipoproteins result in an increased susceptibility to phospholipid hydrolysis by phospholipase A2 Atherosclerosis1997132165769242962
   PubMed Web of Science ®Google Scholar
• FontehANBassDAMarshallLAEvidence that secretory phospholipase A2 plays a role in arachidonic acid release and eicosanoid biosynthesis by mast cellsJ Immunol19941525438468189063
   PubMed Web of Science ®Google Scholar
• FourcadeOLe BalleFFauvelJRegulation of secretory type-II phospholipase A2 and of lysophosphatidic acid synthesisAdv Enzyme Regul199838991079762349
   PubMedGoogle Scholar
• GesquiereLChoWSubbaiahPVRole of group IIA and group V secretory phospholipases A2 in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelinBiochemistry20024149112011939786
   PubMed Web of Science ®Google Scholar
• GranataFBalestrieriBPetraroliASecretory phospholipases A2 as multivalent mediators of inflammatory and allergic disordersInt Arch Allergy Immunol200313115312876405
   PubMed Web of Science ®Google Scholar
• GreenJASmithGMBuchtaRCirculating phospholipase A2 activity associated with sepsis and septic shock is indistinguishable from that associated with rheumatoid arthritisInflammation199115355671757123
   PubMed Web of Science ®Google Scholar
• HakalaJKOorniKPentikainenMOLipolysis of LDL by human secretory phospholipase A2 induces particle fusion and enhances the retention of LDL to human aortic proteoglycansArterioscler Thromb Vasc Biol2001211053811397719
   PubMed Web of Science ®Google Scholar
• HanWKSapirsteinAHungCCCross-talk between cytosolic phospholipase A2 alpha (cPLA2 alpha) and secretory phospholipase A2 (sPLA2) in hydrogen peroxide-induced arachidonic acid release in murine mesangial cells: sPLA2 regulates cPLA2 alpha activity that is responsible for arachidonic acid releaseJ Biol Chem2003278241536312676927
   PubMed Web of Science ®Google Scholar
• HanasakiKYamadaKYamamotoSPotent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formationJ Biol Chem20022772911612021277
   PubMed Web of Science ®Google Scholar
• HayakawaMKudoITomitaMPurification and characterization of membrane-bound phospholipase A2 from rat plateletsJ Biochem (Tokyo)198810326363372490
   PubMed Web of Science ®Google Scholar
• HayekTAviramMHeinrichRLosartan Inhibits Cellular Uptake of Oxidized LDL by Monocyte-Macrophages from Hypercholesterolemic PatientsBiochemical and Biophysical Research Communications20002734172010873620
   PubMed Web of Science ®Google Scholar
• HeineckeJWSuitsAGAviramMPhagocytosis of lipase-aggregated low density lipoprotein promotes macrophage foam cell formation. Sequential morphological and biochemical eventsArterioscler Thromb1991111643511657129
   PubMedGoogle Scholar
• HernandezMBurilloSLCrespoMSSecretory phospholipase A2 activates the cascade of mitogen-activated protein kinases and cytosolic phospholipase A2 in the human astrocytoma cell line 1321N1J Biol Chem19982736069417122
   PubMed Web of Science ®Google Scholar
• HidiRVargaftigBBTouquiLIncreased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages: dissociation from arachidonic acid liberation and modulation by dexamethasoneJ Immunol19931515613023
   Web of Science ®Google Scholar
• Hurt-CamejoEAndersenSStandalRLocalization of non-pancreatic secretory phospholipase A2 in normal and atherosclerotic arteries. Activity of the isolated enzyme on low-density lipoproteinsArterioscler Thromb Vasc Biol19971730099081685
   PubMed Web of Science ®Google Scholar
• Hurt-CamejoECamejoGPeilotHPhospholipase A2 in vascular diseaseCirc Res20018929830411509445
   PubMed Web of Science ®Google Scholar
• IvandicBCastellaniLWWangXPRole of group II secretory phospholipase A2 in atherosclerosis. 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIA phospholipase A2Arterioscler Thromb Vasc Biol19991912849010323781
   PubMed Web of Science ®Google Scholar
• JarossWEckeyRMenschikowskiMBiological effects of secretory phospholipase A(2) group IIA on lipoproteins and in atherogenesisEur J Clin Invest2002323839312059982
   PubMed Web of Science ®Google Scholar
• KeidarSKaplanMHoffmanAAng-II stimulates macrophage-mediated oxidation of LDLAtherosclerosis1995115201157661879
   PubMed Web of Science ®Google Scholar
• KeidarSAttiasJSmithJThe angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient miceBiochem Biophys Res Comm199723662259245700
   PubMed Web of Science ®Google Scholar
• KeidarSAngiotensin, LDL peroxidation and AtherosclerosisLife Sciences199863ll11
   Google Scholar
• KeidarSAttiasJHeinrichRAng-II atherogenicity in E0 mice is associated with increased cellular cholesterol biosynthesisAtherosclerosis19991462495710532681
   PubMed Web of Science ®Google Scholar
• KeidarSHeinrichRKaplanMAngiotensin II administration to atherosclerotic mice increases macrophage uptake of oxidized LDL: a possible role for interleukin-6Arterioscler Thromb Vasc Biol2001211464911557673
   PubMed Web of Science ®Google Scholar
• KorotaevaAASamoilovaEVKaminnyAIThe catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDLMol Cell Biochem200527010711315792359
   PubMed Web of Science ®Google Scholar
• KovanenPTPentikainenMOSecretory group II phospholipase A2; a newly recognized acute-phase reactant with a role in atherogenesisCirc Res2000866101210746993
   PubMed Web of Science ®Google Scholar
• KudoIMurakamiMPhospholipase A2 enzymesProstaglandins Other Lipid Mediat200268-6935812432908
   PubMed Web of Science ®Google Scholar
• KugiyamaKOtaYTakazoeKCirculating levels of secretory type II phospholipase A(2) predict coronary events in patients with coronary artery diseaseCirculation19991001280410491371
   PubMed Web of Science ®Google Scholar
• KugiyamaKOtaYSugiyamaSPrognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectorisAm J Cardiol2000867182211018189
   PubMed Web of Science ®Google Scholar
• KuriharaHNakanoTTakasuNIntracellular localization of group II phospholipase A2 in rat vascular smooth muscle cells and its possible relationship to eicosanoid formationBiochim Biophys Acta19911082285922029548
   PubMedGoogle Scholar
• LaineVJOGrassDSNevalainenTJProtection by group II phospholipase A2 against Staphylococcus aureusJ Immunol19991627402810358193
   PubMed Web of Science ®Google Scholar
• LeitingerNWatsonADHamaSYRole of group II secretory phopholipase A2 in atherosclerosis: 2. Potential involvment of biologically active oxidized phospholipidsArterioscler Thromb Vasc Biol1999191291810323782
   PubMed Web of Science ®Google Scholar
• LeslieCCProperties and regulation of cytosolic phospholipase A2J Biol Chem199727216709129201969
   PubMed Web of Science ®Google Scholar
• LiuPYLiYHTsaiWCPrognostic value and the changes of plasma levels of secretory type II phospholipase A2 in patients with coronary artery disease undergoing percutaneous coronary interventionEur Heart J20032418243214563341
   PubMed Web of Science ®Google Scholar
• LoweLPGreenlandPRuthKJImpact of major cardiovascular disease risk factors, particularly in combination, on 22-year mortality in women and menArch Intern Med19981582007149778200
   PubMed Web of Science ®Google Scholar
• LuchtefeldMBandlowNTietgeUJAngiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A(2)-dependent lipid peroxidationAtherosclerosis20062525
   Google Scholar
• MallatZStegPGBenessianoJCirculating secretory phospholipase A2 activity predicts recurrent events in patients with severe acute coronary syndromesJ Am Coll Cardiol20054612495716198839
   PubMed Web of Science ®Google Scholar
• MallatZBenessianoJSimonTCirculating secretory phospholipase A2 activity and risk of incident coronary events in healthy men and women: The EPIC-NORFOLK StudyArterioscler Thromb Vasc Biol20072711778317303774
   PubMed Web of Science ®Google Scholar
• MehtaJLLiDFacilitative interaction between angiotensin II and oxidized LDL in cultured human coronary artery endothelial cellsJ Renin Angiotensin Aldosterone Syst20012S70S76
   PubMed Web of Science ®Google Scholar
• MehtaJLLiDIdentification, regulation and function of a novel lectin like oxidized low density lipoprotein receptorJ Am Coll Cardiol2002391429143511985903
   PubMed Web of Science ®Google Scholar
• MenschikowskiMEckeyRPietzschJExpression of human secretory group IIA phospholipase A2 is associated with reduced concentrations of plasma cholesterol in transgenic miceInflammation20002422737
   Web of Science ®Google Scholar
• MenschikowskiMRosner-SchieringAEckeyRExpression of secretory group IIA phospholipase A(2) in relation to the presence of microbial agents, macrophage infiltrates, and transcripts of proinflammatory cytokines in human aortic tissuesArterioscler Thromb Vasc Biol2000207516210712401
   PubMed Web of Science ®Google Scholar
• MenschikowskiMHagelgansASiegertGSecretory phospholipase A2 of group IIA: Is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?Prostaglandins Other Lipid Mediat20067913316516807
   PubMed Web of Science ®Google Scholar
• MurakamiMKudoIInoueKMolecular nature of phospholipase A2 involved in prostaglandin I2 synthesis in human umbilical vein endothelial cells: possible participation of cytosolic and extracellular type II phospholipase A2J Biol Chem1993268839448419361
   PubMed Web of Science ®Google Scholar
• MurakamiMKudoINew phospholipase A2 isozymes with a potential role in atherosclerosisCurr Opin Lipidol200314431614501581
   PubMed Web of Science ®Google Scholar
• MurakamiMKudoISecretory phospholipase A2Biol Pharm Bull20042711586415305013
   PubMed Web of Science ®Google Scholar
• NakanoTOharaOTeraokaHGlucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expressionJ Biol Chem19902651274582373711
   PubMed Web of Science ®Google Scholar
• NeatonJDWentworthDSerum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research GroupArch Intern Med199215256641728930
   PubMed Web of Science ®Google Scholar
• NickenigGWassmannSBohmMRegulation of the angiotensin AT1 receptor by hypercholesterolaemiaDiabetes Obes Metab20002223811225655
   PubMed Web of Science ®Google Scholar
• NiessenHWKrijnenPAVisserCAType II secretory phospholipase A2 in cardiovascular disease: a mediator in atherosclerosis and ischemic damage to cardiomyocytes?Cardiovasc Res2003606814522408
   PubMed Web of Science ®Google Scholar
• PeilotHRosengrenBBondjersGInterferon-g induces secretory group IIA phospholipase A2 in human arterial smooth muscle cells: involvement of cell differentiation, STAT-3 activation, and modulation by other cytokinesJ Biol Chem20002752289590410811652
   PubMed Web of Science ®Google Scholar
• PfeilschifterJPignatWVosbeckKInterleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat mesangial cellsBiochem Biophys Res Commun1989159385942784674
   PubMed Web of Science ®Google Scholar
• PickardRTStriflerBAKramerRMMolecular cloning of two new human paralogs of 85-kDa cytosolic phospholipase A2J Biol Chem199927488233110085124
   PubMed Web of Science ®Google Scholar
• PruzanskiWStefanskiEVadasPRegulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factorsBiochim Biophys Acta1998140347569622592
   PubMed Web of Science ®Google Scholar
• ReddySTHerschmanHRTranscellular prostaglandin production following mast cell activation is mediated by proximal secretory phospholipase A2 and distal prostaglandin synthase 1J Biol Chem1996272186918550557
   PubMedGoogle Scholar
• ReddySTHerschmanHRProstaglandin synthase-1 and prostaglandin synthase-2 are coupled to distinct phospholipases for the generation of prostaglandin D2 in activated mast cellsJ Biol Chem1997272323179013559
   PubMed Web of Science ®Google Scholar
• RomanoMRomanoEBjorkerudSUltrastructural localization of secretory type II phospholipase A2 in atherosclerotic and nonatherosclerotic regions of human arteriesArterioscler Thromb Vasc Biol199818519259555856
   PubMed Web of Science ®Google Scholar
• RosengrenBPeilotHUmaerusMSecretory phospholipase A2 type IIA and V in atherosclerosis: expression by vascular cells, localization in lesions and hydrolysis of lipoproteinsAtherosclerosis Suppl20045147
   Web of Science ®Google Scholar
• RossRAtherosclerosis – an inflammatory diseaseN Engl J Med1999340115269887164
   PubMed Web of Science ®Google Scholar
• SapirsteinABonventreJVSpecific physiological roles of cytosolic phospholipase A(2) as defined by gene knockoutsBiochim Biophys Acta200014881394811080683
   PubMed Web of Science ®Google Scholar
• SartipyPBondjersGHurt-CamejoEPhospholipase A2 type II binds to extracellular matrix biglycan: modulation of its activity on LDL by colocalization in glycosaminoglycan matrixesArteioscler Thromb Vasc Biol199818193441
   PubMed Web of Science ®Google Scholar
• SartipyPJohansenBGasvikKMolecular basis for the association of group IIA phospholipase A2 and decorin in human atherosclerotic lesionsCirc Res2000867071410747008
   PubMed Web of Science ®Google Scholar
• SchalkwijkCPfeilschifterJMärkiFInterleukin 1β, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cellsBiochem Biophys Res Commun1991174268751989605
   PubMed Web of Science ®Google Scholar
• ShodaJKanoMAsanoTSecretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitisHepatology19992910263610094942
   PubMed Web of Science ®Google Scholar
• SillimanCCMooreEEZallenGPresence of the M-type sPLA2 receptor on neutrophils and its role in elastase release and adhesionAm J Physiol Cell Physiol2002283C110212225974
   PubMed Web of Science ®Google Scholar
• SixDADennisEAThe expanding superfamily of phospholipase A2 enzymes: classification and characterizationBiochim Biophys Acta2000148811911080672
   PubMed Web of Science ®Google Scholar
• SnitkoYYoonETChoWHigh specificity of human secretory class II phospholipase A2 for phosphatidic acidBiochem J1997321737419032461
   PubMed Web of Science ®Google Scholar
• SparrowCPParathasarathySSteinbergDEnzymatic modification of low density lipoprotein by purified lipoxygenase plus phospholipase A2 mimics cell-mediated oxidative modificationJ Lipid Res198829745533139813
   PubMed Web of Science ®Google Scholar
• TadaKMurakamiMKambeTInduction of cyclooxygenase-2 by secretory phospholipases A2 in nerve growth factor-stimulated rat serosal mast cells is facilitated by interaction with fibroblasts and mediated by a mechanism independent of their enzymatic functionsJ Immunol199816150089794438
   PubMed Web of Science ®Google Scholar
• TaniguchiHMomiyamaYOhmoriRAssociations of plasma C-reactive protein levels with the presence and extent of coronary stenosis in patients with stable coronary artery diseaseAtherosclerosis2005178173715585215
   PubMed Web of Science ®Google Scholar
• ThomasFBeanKGuizeLCombined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and womenEur Heart J2002235283511922642
   PubMed Web of Science ®Google Scholar
• TietgeUJFMaugeaisCCainWOverexpression of Secretory Phospholipase A2 causes rapid catabolism and altered tissue uptake of high density lipoprotein cholesteryl ester and apolipoprotein A-I*J Biol Chem2000275100778410744687
   PubMed Web of Science ®Google Scholar
• TietgeUJPraticoDDingTMacrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stressJ Lipid Res200546160415897607
   PubMed Web of Science ®Google Scholar
• VadasPPruzanskiWInduction of group II phospholipase A2 expression and pathogenesis of the sepsis syndromeCirc Shock19933916078490995
   PubMedGoogle Scholar
• ValentinEGhomashchiFGelbMHOn the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymesJ Biol Chem19992743119520210531313
   PubMed Web of Science ®Google Scholar
• VialDSenorale-PoseMHavetNExpression of type-II phospholipase A2 in alveolar macrophages: down-regulation by an inflammatory signalJ Biol Chem199527017327327615534
   PubMed Web of Science ®Google Scholar
• WebbNRSecretory phospholipase A2 enzymes in atherogenesisCurr Opin Lipidol200516341415891396
   PubMed Web of Science ®Google Scholar
• Wooton-KeeCRBoyanovskyBBNasserMGroup V sPLA2 hydrolysis of LDL results in spontaneous particle aggregation and promotes macrophage foam cell formationArterioscler Thromb Vasc Biol200424762714962950
   PubMed Web of Science ®Google Scholar
• WrightGWOoiCEWeissJPurification of a cellular (granulocyte) and an extracellular (serum) phospholipase A2 that participate in the destruction of Escherichia coli in a rabbit inflammatory exudateJ Biol Chem19902656675812182625
   PubMed Web of Science ®Google Scholar
• YuanYJacksonSPNewnhamHHAn essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2Blood1995864166747492774
   PubMed Web of Science ®Google Scholar